LYEL Past Earnings image   This LYEL past earnings page last updated 3/11/2024
LYEL Past Earnings
PeriodPast Earnings DateAdj. EPS
Q4 20232/28/2024-0.170
Q3 202311/7/2023-0.170
Q2 20238/8/2023-0.040
Q1 20235/4/2023-0.180
Q4 20222/28/20230.000
Q3 202211/8/2022-0.180
Q2 20228/4/2022-0.040
Q1 20225/10/2022-0.200
Q4 20213/29/2022-0.170
Q3 202111/12/2021-0.150
Q2 20218/12/2021-0.890
LYEL Past Revenue
PeriodPast Earnings DateGAAP
Q4 20232/28/20240.01M
Q3 202311/7/20230.03M
Q2 20238/8/20230.03M
Q1 20235/4/20230.07M
Q4 20222/28/20230.05B
Q3 202211/8/20220.00M
Q2 20228/4/20220.04B
Q1 20225/10/20220.00B
Q4 20213/29/20220.00B
Q3 202111/12/20210.00B
Q2 20218/12/20210.00B
Quotes delayed 20 minutes

Email EnvelopeFree LYEL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Lyell Immunopharma (LYEL) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

LYRA Past Earnings
MACK Past Earnings
MASI Past Earnings
MBIO Past Earnings
MBOT Past Earnings
MBRX Past Earnings
MCK Past Earnings
MCRB Past Earnings
MD Past Earnings
MDGL Past Earnings

LYEL Past Earnings Q&A

What was the best and worst LYEL past earnings results?
For Lyell Immunopharma, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest LYEL past earnings result in our data set was 0.000/share posted in Q4 2022, while the lowest was in Q2 2021 when LYEL posted -0.890/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2022 when LYEL reported 0.05B in revenue, while the quarter with the lowest revenue in our data set was Q3 2022 at 0.00M of revenue.

  Suggested answer: There are 11 LYEL past earnings results in our data set.

On this page we presented the LYEL past earnings date information for Lyell Immunopharma. Reviewing that LYEL Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2022, when LYEL posted adjusted EPS of 0.000/share. Meanwhile the lowest LYEL past earnings result was in Q2 2021, when LYEL posted adjusted EPS of -0.890/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2022 when LYEL reported 0.05B in revenue, while the smallest revenue quarter was Q3 2022 when LYEL reported 0.00M in revenue.

Any self directed investor doing their due diligence on LYEL or any other given stock can benefit from researching all of the Lyell Immunopharma past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Lyell Immunopharma past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LYEL. Thanks for visiting, and the next time you need to research LYEL past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: MWA Dividend History, MYGN YTD Return, ZMTP Insider Buying.


LYEL Past Earnings | | Copyright © 2020 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.